Morgan Stanley Tactical Value Provides Up to $150MM Non-Dilutive Term Loan to Fibrogen
FibroGen entered into a non-dilutive term loan facility with investment funds managed by Morgan Stanley Tactical Value that will result in proceeds to FibroGen of up to $150 million, providing non-dilutive capital to support growth and innovation.
May 2, 2023
Enrique Conterno | FibroGen | Gibson Dunn & Crutcher | Goodwin Procter | Morgan Stanley | Morgan Stanley Tactical Value | Tom Cahill
Ian Koplin